Body mass index identified as an independent predictor of psychiatric readmission

Journal of Clinical Psychiatry

Volumn 75, Issue 6, 2014, Pages

  Manu, Peter ^a,b,c   Khan, Sameer ^d   Radhakrishnan, Rajiv ^e   Russ, Mark J ^a,b,c   Kane, John M ^a,b,c   Correll, Christoph U ^a,b,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL INFORMATION; MENTAL DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; UNITED STATES;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CLOZAPINE; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; LENGTH OF STAY; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84903519336     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08795     Document Type: Article

References (37)

1. McCarthy D, Johnson MB, Audet AM. Recasting readmissions by placing the hospital role in community context. JAMA. 2013;309(4):351-352. doi:10.101/jama.2013.1 PubMed
2. Kansagara D, Englander H, Salanitro A, et al. Risk prediction models for hospital readmission: a systematic review. JAMA. 2011;306(15):1688-1698. doi:10.101/jama.201.1515 PubMed
3. Lin CH, Chen WL, Lin CM, et al. Predictors of psychiatric readmissions in the short- and long-term: a population-based study in Taiwan. Clinics (Sao Paulo). 2010;65(5):481-489. doi:10.1590/S1807-5932010505 PubMed
4. Appleby L, Luchins DJ, Desai PN, et al. Length of inpatient stay and recidivism among patients with schizophrenia. Psychiatr Serv. 1996;47(9):985-990. PubMed (Pubitemid 26303423)
5. Zilber N, Hornik-Lurie T, Lerner Y. Predictors of early psychiatric rehospitalization: a national case register study. Isr J Psychiatry Relat Sci. 2011;48(1):49-53. PubMed
6. Zhang J, Harvey C, Andrew C. Factors associated with length of stay and the risk of readmission in an acute psychiatric inpatient facility: a retrospective study. Aust N Z J Psychiatry. 2011;45(7):578-585. doi:10.3109/048674.201.585452 PubMed
7. Prince JD, Akincigil A, Kalay E, et al. Psychiatric rehospitalization among elderly persons in the United States. Psychiatr Serv. 2008;59(9):1038- 1045. doi:10.176/api.ps.59.9.1038 PubMed
8. Byrne SL, Hooke GR, Page AC. Readmission: a useful indicator of the quality of inpatient psychiatric care. J Affect Disord. 2010;126(1-2):206-213. doi:10.1016/j.jad.2010.02.135 PubMed
9. Irmiter C, McCarthy JF, Barry KL, et al. Reinstitutionalization following psychiatric discharge among VA patients with serious mental illness: a national longitudinal study. Psychiatr Q. 2007;78(4):279-286. doi:10.107/s126-07-9046-y PubMed (Pubitemid 350112266)
10. Schennach R, Obermeier M, Meyer S, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2012;63(1):87-90. doi:10.176/api.ps.201084 PubMed
11. van Walraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6):551-557. doi:10.1503/cmaj.0917 PubMed
12. Hasan O, Meltzer DO, Shaykevich SA, et al. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med. 2010;25(3):211-219. doi:10.107/s1606-09-196-1 PubMed
13. Au AG, McAlister FA, Bakal JA, et al. Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. Am Heart J. 2012;164(3):365-372. doi:10.1016/j.ahj.2012.06.010 PubMed
14. Garrison GM, Mansukhani MP, Bohn B. Predictors of thirty-day readmission among hospitalized family medicine patients. J Am Board Fam Med. 2013;26(1):71-77. doi:10.312/jabfm.2013.01.120107 PubMed
15. Hannan EL, Zhong Y, Lahey SJ, et al. 30-day readmissions after coronary artery bypass graft surgery in New York State. JACC Cardiovasc Interv. 2011;4(5):569-576. doi:10.1016/j.jcin.201.01.010 PubMed
16. Ko FW, Tam W, Tung AH, et al. A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD. Respir Med. 2011;105(2):266-273. doi:10.1016/j.rmed.2010.06.02 PubMed
17. Manu P, Asif M, Khan S, et al. Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention. Compr Psychiatry. 2012;53(7):968-974. doi:10.1016/j.compsych.2012.03.05 PubMed
18. Correll CU, Lencz T, Malhotra AK. Antipsychotic drugs and obesity. Trends Mol Med. 2011;17(2):97-107. doi:10.1016/j.molmed.2010.10.010 PubMed
19. Velligan DI, Weiden PJ, Sajatovic M, et al Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The Expert Consensus Guideline Series: Adherence Problems in Patients With Serious and Persistent Mental Illness. J Clin Psychiatry. 2009;70(Suppl 4):1-46, quiz 47-48. doi:10.408/JCP.7090su1cj PubMed
20. Wong MM, Chen EY, Lui SS, et al. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses. 2011;5(3):135-141. doi:10.371/CSRP.5.3.3 PubMed
21. Hodgson RE, Lewis M, Boardman AP. Prediction of readmission to acute psychiatric units. Soc Psychiatry Psychiatr Epidemiol. 2001;36(6):304-309. doi:10.107/s0127017049 PubMed (Pubitemid 32834282)
22. O'Leary DA, Lee AS. Seven year prognosis in depression: mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry. 1996;169(4):423-429. doi:10.192/bjp.169.4.423 PubMed
23. Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and doubleblind comparison. Arch Gen Psychiatry. 2001;58(10):965-972. doi:10.101/archpsyc.58.10. 965 PubMed (Pubitemid 32937920)
24. De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2012;8(2):114-126. doi:10.1038/nrendo.201.156 PubMed
25. Pogge DL, Singer MB, Harvey PD. Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients. J Child Adolesc Psychopharmacol. 2005;15(6):901-912. doi:10.1089/cap.205.15.901 PubMed (Pubitemid 43042981)
26. Leadbetter R, Shutty M, Pavalonis D, et al. Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry. 1992;149(1):68-72. PubMed
27. Czobor P, Volavka J, Sheitman B, et al. Antipsychotic-induced weight gain and therapeutic response: a differential association. J Clin Psychopharmacol. 2002;22(3):244-251. doi:10.1097/04714-202060-03 PubMed (Pubitemid 34546838)
28. Meltzer HY, Perry E, Jayathilake K. Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr Res. 2003;59(1):19-27. doi:10.1016/S0920-964(01)0326-7 PubMed (Pubitemid 35291087)
29. Ascher-Svanum H, Stensland MD, Kinon BJ, et al. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J Psychopharmacol. 2005;19(suppl 6):110-117. doi:10.17/02698105058978 PubMed (Pubitemid 44567865)
30. Bai YM, Lin CC, Chen JY, et al. Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry. 2006;163(7):1276-1279. doi:10.176/api.ajp.163.7.1276 PubMed
31. Hermes E, Nasrallah H, Davis V, et al. The association between weight change and symptom reduction in the CATIE schizophrenia trial. Schizophr Res. 2011;128(1-3):166-170. doi:10.1016/j.schres.201.01.02 PubMed
32. Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:92-99. doi:10.1016/j.pnpbp.2013.05.05 PubMed
33. Dickerson F, Stallings C, Origoni A, et al. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord. 2013;150(2):456-459. doi:10.1016/j.jad.2013.04.039 PubMed
34. Hope S, Ueland T, Steen NE, et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res. 2013;145(1-3):36-42. doi:10.1016/j.schres.2012.12.023 PubMed
35. Callaly T, Hyland M, Trauer T, et al. Readmission to an acute psychiatric unit within 28 days of discharge: identifying those at risk. Aust Health Rev. 2010;34(3):282-285. doi:10.1071/AH08721 PubMed
36. Wheeler A, Moyle S, Jansen C, et al. Five-year follow-up of an acute psychiatric admission cohort in Auckland, New Zealand. N Z Med J. 2011;124(1336):30-38. PubMed
37. Priebe S, Katsakou C, Amos T, et al. Patients' views and readmissions 1 year after involuntary hospitalization. Br J Psychiatry. 2009;194(1):49-54. PubMed